Basket cover image
15 handpicked stocks

Intellectual Property

These companies own valuable ideas, brands, and inventions that generate reliable, contract-guaranteed income. Their asset-light business models create high-margin revenue streams without the costs of physical production, making them potential profit powerhouses across multiple industries.

stock
stock
stock
stock
stock
stock
stock
stock
stock
stock

+5

Author avatar

Han Tan | Market Analyst

Updated 1 day ago | Published at June 17

Top Picks from This Group

Here are a few of the assets in this group. Create an account to unlock the full list.

RPRX

Royalty Pharma plc

RPRX

Current price

$36.35

This company is a leading acquirer of royalty streams from a wide portfolio of biopharmaceutical products and therapies.

WMG

Warner Music Group

WMG

Current price

$32.53

A major music entertainment company, it generates substantial royalty revenue from its extensive catalog of music copyrights and publishing rights.

INVA

Innoviva, Inc.

INVA

Current price

$20.92

The company's portfolio includes significant royalty assets from respiratory therapies partnered with major pharmaceutical firms.

About This Group of Stocks

1

Our Expert Thinking

Instead of factories or inventory, these companies own something even more valuable — protected ideas. They generate predictable income by licensing intellectual assets like drug patents, music rights, and famous brands to others. This creates recurring revenue streams backed by legal agreements, often with minimal overhead costs.

2

What You Need to Know

This group offers exposure to high-margin businesses that don't require heavy infrastructure investments. Their income tends to be contractually protected and diversified across industries from pharmaceuticals to entertainment. While these companies can deliver steady cash flow, their performance ultimately depends on the ongoing value of their intangible assets.

3

Why These Stocks

We've selected pure-play royalty firms in biotech and media alongside established companies with significant licensing operations. These businesses are positioned to potentially benefit from accelerating digital transformation and continued innovation in life sciences, which constantly create new valuable intellectual property opportunities.

12 Month Growth Potential

Use the growth calculator to see how much investing in these assets could return over one year.

If you invested across these assets:

in 12 months it could be worth:

$1,000.00

+70.28%

Group Performance Snapshot

70.28%

Average 12 Month Profit

On average, analysts expect assets in this group to grow 70.28% over the next year.

15 of 15

Stocks Rated Buy by Analysts

15 of 15 assets in this group are rated Buy by professional analysts.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Why You'll Want to Watch These Stocks

💰

Recurring Royalty Income

These companies earn money every time someone uses their intellectual property, creating potential for steady, predictable revenue streams without hefty production costs.

📝

Contract-Protected Profits

Many of these businesses lock in multi-year licensing deals that provide revenue visibility others simply don't have. This contracted income can help weather market volatility.

🚀

Digital Age Accelerators

As streaming platforms expand and biotech innovation accelerates, the demand for licensable intellectual property continues to grow, potentially giving these companies significant tailwinds.

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Uncle Sam's Semiconductor Stake

Uncle Sam's Semiconductor Stake

The U.S. government is considering an equity stake in Intel to boost domestic semiconductor manufacturing. This strategic move could create a ripple effect, benefiting other American companies involved in the chip-making industry.

View stocks
The Cybersecurity Consolidation Wave

The Cybersecurity Consolidation Wave

Accenture's record-breaking acquisition of CyberCX signals a major consolidation trend in the cybersecurity sector. This move highlights the growing demand for AI-powered security solutions, creating potential opportunities for other specialized cybersecurity firms to benefit from increased investment and M&A activity.

View stocks
American Chipmakers: A Tariff-Driven Shift

American Chipmakers: A Tariff-Driven Shift

President Trump has threatened to impose tariffs of up to 300% on semiconductors to boost domestic production. This creates a potential investment opportunity in U.S.-based semiconductor companies that stand to gain from a shift toward onshore manufacturing.

View stocks
View All

Frequently Asked Questions

Everything you need to know about the product and billing.